AK Steel Enters Licensing Agreement Involving Its ULTRALUME® PHS High Strength, High Formability Steel Product
28 oct. 2019 11h30 HE
|
AK Steel
WEST CHESTER, Ohio, Oct. 28, 2019 (GLOBE NEWSWIRE) -- AK Steel (NYSE: AKS) announced today that it has entered into a licensing agreement involving its aluminized boron press hardenable steel...
Dakshidin Corporation (DKSC), Signs LOI for Worldwide Exclusive Licensing Agreement
15 janv. 2019 09h56 HE
|
Dakshidin Corporation
LAS VEGAS, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Dakshidin Corporation (DKSC) announced today that it had signed a Letter of Intent for a worldwide exclusive licensing agreement with GenBio, a...
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
05 sept. 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year...
Mission Ready Provides Unifire and Recent Progress Update, Contemplates Streamlined Licensing Arrangement with Foreign Military Distributor in Advance of Anticipated Orders
07 août 2018 17h24 HE
|
Mission Ready Solutions Inc.
VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV:MRS) is pleased to provide an update on the Company’s forward...
Summit Enters Into Licence and Commercialisation Agreement With Eurofarma for Latin American Rights to Ridinilazole, Summit’s Precision Antibiotic in Development for the Treatment of CDI
21 déc. 2017 02h00 HE
|
Summit Therapeutics plc
Summit to receive $2.5 million upfront paymentUp to $25 million in development, regulatory, pricing and initial sales milestonesSummit retains commercial rights to ridinilazole in rest of the world ...
Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan
21 févr. 2017 07h05 HE
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs
09 janv. 2017 08h00 HE
|
Assembly Biosciences, Inc.
-- Expands Allergan’s Innovative GI Pipeline with ABI-M201 and ABI-M301, Preclinical Compounds Targeting Ulcerative Colitis and Crohn’s Disease, as well as Future Compounds for Irritable Bowel...
Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200
09 juin 2015 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...
![App Icon Alice1](http://www.globenewswire.com/fr/Attachment/LogoDisplay/305678?filename=305678.jpg&size=2)
Soul and Vibe Licenses Its Games to Tanjarine
24 juil. 2014 07h00 HE
|
Soul and Vibe Interactive Inc.
MINNEAPOLIS, July 24, 2014 (GLOBE NEWSWIRE) -- Soul and Vibe Interactive Inc. (OTCQB:SOUL), "The Company," a video and computer games company, today announced that it has entered into a license...
![Tauriga Sciences, Inc.](/news-release/logo/254204/0/254204.jpg?lastModified=12%2F09%2F2016%2023%3A09%3A31&size=2)
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
16 juil. 2014 15h30 HE
|
Tauriga Sciences Inc
LOS ANGELES, July 16, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company"), a diversified life sciences company, announced today it has signed a non-exclusive...